Biote earnings were $21.8M for the trailing 12 months ending Mar 31, 2025, with 250% growth year over year. The latest BTMD earnings report on Mar 31, 2025 announced Q1 2025 earnings of $13.7M, up 270.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BTMD reported annual earnings of $3.2M, with -4.8% growth.
BTMD past earnings growth
How has BTMD's earnings growth performed historically?
Biote (NASDAQ: BTMD) reported Q1 2025 earnings per share (EPS) of $0.44, up 466.67% year over year. Total BTMD earnings for the quarter were $13.72 million. In the same quarter last year, Biote's earnings per share (EPS) was -$0.12.
As of the last Biote earnings report, Biote is currently profitable. Biote's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $21.80 million, a 265.79% increase year over year.
What was BTMD's earnings growth in the past year?
As of Biote's earnings date in Q2 2025, Biote's earnings has grown 250% year over year. This is 237.28 percentage points higher than the US Medical Care Facilities industry earnings growth rate of 12.72%. BTMD earnings in the past year totalled $21.80 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.